NAS:ATRI (USA)
Atrion Corp $ 736.00 37.69 (5.4%)
On watch
Volume:
7,688
Avg Vol (1m):
8,508
Market Cap $:
1.35 Bil
Enterprise Value $:
1.30 Bil
P/E (TTM):
41.47
P/B:
5.67
Current and historical daily P/E ratio for ATRI (Atrion Corp) from 1990 to Jan 22 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Atrion stock (ATRI) PE ratio as of Jan 22 2021 is 41.47.
More Details
Atrion PE Ratio (TTM) Chart
EMBED
Atrion PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1256
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Atrion PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2021-01-23 | 41.5 | 2020-11-20 | 33.4 |
| 2021-01-22 | 41.5 | 2020-11-19 | 33.9 |
| 2021-01-21 | 39.3 | 2020-11-18 | 33.0 |
| 2021-01-20 | 40.0 | 2020-11-17 | 33.9 |
| 2021-01-19 | 41.2 | 2020-11-16 | 34.5 |
| 2021-01-15 | 41.4 | 2020-11-13 | 33.5 |
| 2021-01-14 | 39.9 | 2020-11-12 | 33.2 |
| 2021-01-13 | 38.2 | 2020-11-11 | 33.0 |
| 2021-01-12 | 38.3 | 2020-11-10 | 33.5 |
| 2021-01-11 | 38.0 | 2020-11-09 | 34.4 |
| 2021-01-08 | 37.6 | 2020-11-06 | 33.9 |
| 2021-01-07 | 37.4 | 2020-11-05 | 34.0 |
| 2021-01-06 | 37.6 | 2020-11-04 | 34.1 |
| 2021-01-05 | 36.7 | 2020-11-03 | 34.5 |
| 2021-01-04 | 36.9 | 2020-11-02 | 34.4 |
| 2021-01-01 | 36.2 | 2020-10-30 | 33.9 |
| 2020-12-31 | 36.2 | 2020-10-29 | 34.5 |
| 2020-12-30 | 36.1 | 2020-10-28 | 34.4 |
| 2020-12-29 | 35.9 | 2020-10-27 | 35.6 |
| 2020-12-28 | 35.8 | 2020-10-26 | 36.3 |
| 2020-12-25 | 35.5 | 2020-10-23 | 36.9 |
| 2020-12-24 | 35.5 | 2020-10-22 | 37.7 |
| 2020-12-23 | 35.4 | 2020-10-21 | 37.1 |
| 2020-12-22 | 36.2 | 2020-10-20 | 36.8 |
| 2020-12-21 | 35.2 | 2020-10-19 | 36.9 |
| 2020-12-18 | 36.1 | 2020-10-16 | 37.9 |
| 2020-12-17 | 35.1 | 2020-10-15 | 37.1 |
| 2020-12-16 | 34.8 | 2020-10-14 | 36.4 |
| 2020-12-15 | 35.4 | 2020-10-13 | 36.6 |
| 2020-12-14 | 35.1 | 2020-10-12 | 36.8 |
| 2020-12-11 | 35.1 | 2020-10-09 | 36.1 |
| 2020-12-10 | 34.7 | 2020-10-08 | 35.2 |
| 2020-12-09 | 34.7 | 2020-10-07 | 35.4 |
| 2020-12-08 | 35.4 | 2020-10-06 | 35.0 |
| 2020-12-07 | 34.8 | 2020-10-05 | 35.2 |
| 2020-12-04 | 36.0 | 2020-10-02 | 34.1 |
| 2020-12-03 | 34.7 | 2020-10-01 | 34.4 |
| 2020-12-02 | 34.3 | 2020-09-30 | 35.3 |
| 2020-12-01 | 34.3 | 2020-09-29 | 35.1 |
| 2020-11-30 | 33.8 | 2020-09-28 | 35.8 |
| 2020-11-27 | 33.5 | 2020-09-25 | 33.3 |
| 2020-11-26 | 33.3 | 2020-09-24 | 33.4 |
| 2020-11-25 | 33.3 | 2020-09-23 | 33.3 |
| 2020-11-24 | 33.0 | 2020-09-22 | 33.6 |
| 2020-11-23 | 32.5 | 2020-09-21 | 33.6 |
Atrion PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Compare
NAS:LMNX
NYSE:CMD
NAS:OSUR
NYSE:GKOS
NAS:STAA
NAS:LMAT
NAS:ATRS
NAS:ANGO
NAS:ATRC
NAS:KRMD
NYSE:BDX
NAS:ISRG
XPAR:EL
NYSE:BAX
OCSE:COLO B
TSE:7741
XSWX:ALC
TSE:4543
XPAR:DIM
NYSE:RMD
Traded in other countries
ATRI.USA
Address
One Allentown Parkway, Allen, TX, USA, 75002
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.